Switching to olmesartan medoxomil/amlodipine vs continuing amlodipine monotherapy in Chinese patients with mild-to-moderate essential hypertension
Phase of Trial: Phase III
Latest Information Update: 20 Nov 2012
At a glance
- Drugs Olmesartan medoxomil/amlodipine (Primary) ; Amlodipine
- Indications Essential hypertension
- Focus Therapeutic Use
- 20 Nov 2012 New trial record
- 04 Oct 2012 Primary endpoint 'Seated-blood-pressure' has been met.
- 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.